Cinacalcet Tablet
Product Images NDC 72162-2527

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Cinacalcet (NDC 72162-2527). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (00722e4a 7103 49ef 8cfd 6a14b0088f0e 01)

Chemical structure of cinacalcet hydrochloride showing the molecular arrangement including trifluoromethyl-substituted aromatic ring and other characteristic groups.*

FDA Label Image

Image (00722e4a 7103 49ef 8cfd 6a14b0088f0e 02)

A line chart comparing parathyroid hormone (PTH) levels (pg/mL) over 26 weeks between placebo (black dashed line) and Cinacalcet tablets (red solid line). The chart shows PTH levels decreasing over time with Cinacalcet tablets, while levels remain relatively stable with placebo.*

FDA Label Image

Image (00722e4a 7103 49ef 8cfd 6a14b0088f0e 03)

A line chart comparing the levels of Ca × P (mg/dL) over 26 weeks between placebo and Cinacalcet tablets. The y-axis represents Ca × P (mg/dL) values, and the x-axis represents the weeks of treatment. The graph shows a decrease in Ca × P levels in the Cinacalcet group over time compared to the placebo group which remains relatively stable.*

FDA Label Image

Image (00722e4a 7103 49ef 8cfd 6a14b0088f0e 04)

A line graph showing calcium concentration (mg/dL) over time in weeks, with data points marked from baseline through week 80. The x-axis is labeled with week numbers and phases marked as 'Titration' and 'Maintenance.' The y-axis ranges from 8 to 16 mg/dL. Error bars indicate variability at each time point. The graph includes a legend noting 'Parathyroid Carcinoma (n)' with sample sizes listed for several weeks.*

FDA Label Image

Image (00722e4a 7103 49ef 8cfd 6a14b0088f0e 05)

A line chart depicting serum calcium levels (in mg/dL) over a period of 80 weeks, marked by titration, end of titration (EOT), and maintenance phases. The x-axis shows weeks with associated intractable pHPT patient counts, and the y-axis represents calcium concentration. Data points include error bars indicating variability.*

FDA Label Image

Label (Lbl721622527)

Label for Cinacalcet Tablets 90 mg oral tablets, containing Cinacalcet Hydrochloride 99 mg equivalent to Cinacalcet 90 mg. The label indicates a package size of 30 tablets, relabeled by Bryant Ranch Prepack, Inc. and manufactured by Cipla Ltd. Storage instructions and handling warnings are included, with QR codes for package insert and dosage information. The NDC is 72162-2527-3.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.